A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors-Reference-Cited by-同舟云学术

A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors

Published:2014-08-20 Issue:4 Volume:15 Page:540-546
ISSN:1470-3203
Container-title:Journal of the Renin-Angiotensin-Aldosterone System
language:en
Short-container-title:J Renin Angiotensin Aldosterone Syst

Author:

Yu Huimin¹,Lin Shuguang¹,Zhong Jiuchang²,He Min³,Jin Lijun¹,Zhang Yuqing⁴,Liu Guozhang⁴

Affiliation:

1. Department of Cardiology, Guangdong General Hospital, China; Guangdong Academy of Medical Sciences, China

2. State Key Laboratory of Medical Genomics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China; Shanghai Institute of Hypertension, China

3. Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, China

4. Division of Hypertension, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, China; Peking Union Medical College, China

Publisher

Hindawi Limited

Subject

Endocrinology,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1470320313506481

Reference26 articles.

1. Pharmacogenetics of hypertension treatment

2. Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals

3. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

4. Association of polymorphisms in the AGT gene with essential hypertension in the Chinese population

5. Pulse pressure in essential hypertension: clinical and therapeutical implications

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Hypertension in the Asia-Pacific Region: A Structured Review;American Journal of Cardiovascular Drugs;2024-02-08

2. Pharmacogenetic association of the NR1H3 promoter variant with antihypertensive response among patients with hypertension: A longitudinal study;Frontiers in Pharmacology;2023-03-06

3. Identification of disease treatment mechanisms through the multiscale interactome;Nature Communications;2021-03-19

4. Precision Medicine in the Renin-Angiotensin System: Therapeutic Targets and Biological Variability;Current Drug Targets;2020-11-27

5. Identification of disease treatment mechanisms through the multiscale interactome;2020-05-02